Literature DB >> 1477315

The natural immune barrier to xenotransplantation.

R L Geller1, M A Turman, A P Dalmasso, J L Platt.   

Abstract

As the shortage of available organs for transplantation becomes critical, many investigators have turned to the possibility of using animals as a source of donor organs. Although there have been several attempts to use organs from closely related species for transplantation into human, there is relatively little experience in the use of nonprimate animals as clinical donor animals. The major problem in transplants between widely disparate species is hyperacute rejection, a rapid and violent rejection reaction that leads to the destruction of the graft within minutes or hours. Hyperacute rejection appears to be triggered by components of natural immunity, most notably natural antibodies and complement. Recent data suggest that hyperacute rejection may not represent an insurmountable barrier to discordant xenotransplantation. There have recently been several examples of survival of grafts in recipients in the face of antigraft antibodies and an intact complement system referred to as accommodation. Once hyperacute rejection can be averted, it becomes necessary to consider elicited cellular responses. There are a number of issues to be considered in the clinically relevant model of porcine to primate xenografts. These include the size of the responding T-cell repertoire and the extent to which the cell adhesion molecules and cytokines of the donor will be able to stimulate recipient immune responses. Finally, the interactions between T cells and the cells forming the inner layer of blood vessels may have profound effects on the outcome of the graft.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477315     DOI: 10.1681/ASN.V361189

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  3 in total

Review 1.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology.

Authors:  Leah Hennings; Cecile Artaud; Fariba Jousheghany; Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Cancers (Basel)       Date:  2011-11-11       Impact factor: 6.639

3.  AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.

Authors:  Stephen M Shaw; Jenny Middleton; Kim Wigglesworth; Amber Charlemagne; Oliver Schulz; Melanie S Glossop; Giles F Whalen; Robert Old; Mike Westby; Chris Pickford; Rinat Tabakman; Irit Carmi-Levy; Abi Vainstein; Ella Sorani; Arik A Zur; Sascha A Kristian
Journal:  Cancer Cell Int       Date:  2019-12-19       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.